Obesity-Induced Hypertension: New Insights

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|31|4620-4625

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.31, 2017-12, pp. : 4620-4625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Insights in the Treatment Strategy for Pulmonary Arterial Hypertension

By Sahara Makoto   Takahashi Toshiyuki   Imai Yasushi   Nakajima Toshiaki   Yao Atsushi   Morita Toshihiro   Hirata Yasunobu   Nagai Ryozo  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 5, 2006-10 ,pp. : 377-386

Springer Publishing Company

Access to resources Recommend Favorite

New Insights into the Combined Burden of Type 2 Diabetes and Hypertension

By  

Heart Drug, Vol. 3, Iss. 1, 2003-07 ,pp. : 25-33

Karger

Access to resources Recommend Favorite

Chronic Exposure to PCBs (Aroclor 1254) Exacerbates Obesity-Induced Insulin Resistance and Hyperinsulinemia in Mice

By Gray Sarah L.   Shaw Alyssa C.   Gagne Anthony X.   Chan Hing Man  

Journal of Toxicology and Environmental Health, Vol. 76, Iss. 12, 2013-06 ,pp. : 701-715

Taylor & Francis Ltd

Access to resources Recommend Favorite

New Insights in Drug-Induced Mitochondrial Toxicity

By  

Current Pharmaceutical Design, Vol. 17, Iss. 20, 2011-07 ,pp. : 2100-2112

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiology and Treatment of Obesity Hypertension

By  

Current Pharmaceutical Design, Vol. 10, Iss. 29, 2004-11 ,pp. : 3621-3637

Bentham Science Publishers

Access to resources Recommend Favorite